ANA Therapeutics
Founded in response to the COVID-19 pandemic, we’re investigating niclosamide as a treatment for COVID-19.
Launch date
Employees
Market cap
-
Enterprise valuation
€18—27m (Dealroom.co estimates Aug 2020.)
San Mateo California (HQ)
Authorizing premium user...